Back to search

Article

Unveiling the Mechanisms to Bypass KRAS Inhibition: <i>In Vitro</i> Insights into the Influence of Fibroblast-Secretome

2024-04-23

Abstract excerpt

Novel KRAS-targeted therapies unlocked new treatment options for previously untreatable patients. However, in colorectal cancer (CRC), resistance to KRAS-targeted therapy develops rapidly, making it imperative to understand its underlying mechanisms. Cancer-associated fibroblasts (CAFs) induce therapy resistance by generating and maintaining cancer stem cells (CSCs). Additionally, CAFs secretome can modulate KRAS...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a3d96a5e-cc4f-51b0-b978-6a119d718c00
DOI
10.1101/2024.04.19.590324
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Unveiling the Mechanisms to Bypass KRAS Inhibition: <i>In Vitro</i> Insights into the Influence of Fibroblast-SecretomeDOI 10.1101/2024.04.19.590324
Select a neighboring publication to make it the new centre.